Insufficient scRNA-seq data for expression of ELOA2 at single-cell level.
Insufficient scRNA-seq data for expression of ELOA2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 94% | 10.77 | 613 / 653 | 1% | 0.03 | 4 / 605 |
heart | 82% | 7.37 | 706 / 861 | 0% | 0 | 0 / 0 |
kidney | 69% | 4.12 | 61 / 89 | 1% | 0.03 | 5 / 901 |
brain | 66% | 3.50 | 1748 / 2642 | 0% | 0.02 | 1 / 705 |
prostate | 61% | 3.24 | 150 / 245 | 1% | 0.01 | 3 / 502 |
ovary | 59% | 2.79 | 106 / 180 | 0% | 0.01 | 2 / 430 |
skin | 59% | 3.50 | 1059 / 1809 | 0% | 0 | 0 / 472 |
liver | 54% | 2.30 | 123 / 226 | 0% | 0 | 0 / 406 |
breast | 53% | 2.74 | 241 / 459 | 1% | 0.03 | 15 / 1118 |
lung | 50% | 2.80 | 291 / 578 | 0% | 0.01 | 5 / 1155 |
uterus | 49% | 1.91 | 84 / 170 | 0% | 0 | 0 / 459 |
bladder | 48% | 1.62 | 10 / 21 | 0% | 0.00 | 1 / 504 |
adipose | 48% | 1.85 | 573 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 44% | 1.59 | 114 / 258 | 0% | 0 | 0 / 230 |
muscle | 44% | 1.58 | 354 / 803 | 0% | 0 | 0 / 0 |
esophagus | 43% | 1.79 | 619 / 1445 | 1% | 0.01 | 1 / 183 |
blood vessel | 43% | 1.72 | 577 / 1335 | 0% | 0 | 0 / 0 |
spleen | 40% | 1.41 | 97 / 241 | 0% | 0 | 0 / 0 |
intestine | 36% | 1.24 | 345 / 966 | 0% | 0.00 | 1 / 527 |
stomach | 34% | 1.07 | 122 / 359 | 1% | 0.01 | 2 / 286 |
pancreas | 29% | 0.88 | 95 / 328 | 0% | 0 | 0 / 178 |
peripheral blood | 18% | 0.65 | 166 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
GO_0032784 | Biological process | regulation of DNA-templated transcription elongation |
GO_0070449 | Cellular component | elongin complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | ELOA2 |
Protein name | Elongin-A2 (EloA2) (RNA polymerase II transcription factor SIII subunit A2) (Transcription elongation factor B polypeptide 3B) Transcription elongation factor B polypeptide 3B (Elongin A2) |
Synonyms | TCEB3L TCEB3B |
Description | FUNCTION: SIII, also known as elongin, is a general transcription elongation factor that increases the RNA polymerase II transcription elongation past template-encoded arresting sites. Subunit A2 is transcriptionally active but its transcription activity is not enhanced by binding to the dimeric complex of the SIII regulatory subunits B and C (elongin BC complex). . |
Accessions | Q3SY90 ENST00000332567.6 Q8IYF1 |